111 related articles for article (PubMed ID: 9410849)
1. [Responders and nonresponders of ultraviolet A-1 therapy of acute exacerbated atopic eczema].
Kowalzick L; Pönnighaus JM; Suckow M; Waldmann T
Hautarzt; 1997 Sep; 48(9):645-7. PubMed ID: 9410849
[TBL] [Abstract][Full Text] [Related]
2. [Phototherapy in severe atopic dermatitis. Comparison between current UVA1 therapy, UVA1 cold light and combined UVA-UVB therapy].
von Kobyletzki G; Freitag M; Herde M; Höxtermann S; Stücker M; Hoffmann K; Altmeyer P
Hautarzt; 1999 Jan; 50(1):27-33. PubMed ID: 10068928
[TBL] [Abstract][Full Text] [Related]
3. Low dose versus medium dose UV-A1 treatment in severe atopic eczema.
Kowalzick L; Kleinheinz A; Weichenthal M; Neuber K; Köhler I; Grosch J; Lungwitz G; Seegeberg C; Ring J
Acta Derm Venereol; 1995 Jan; 75(1):43-5. PubMed ID: 7538257
[TBL] [Abstract][Full Text] [Related]
4. Monitoring of serologic immune parameters in inflammatory skin diseases.
Gebhardt M; Wenzel HC; Hipler UC; Herrmann D; Wollina U
Allergy; 1997 Nov; 52(11):1087-94. PubMed ID: 9404560
[TBL] [Abstract][Full Text] [Related]
5. Urinary eosinophil protein X and serum eosinophil cationic protein in infants and young children with atopic dermatitis: correlation with disease activity.
Pucci N; Lombardi E; Novembre E; Farina S; Bernardini R; Rossi E; Favilli T; Vierucci A
J Allergy Clin Immunol; 2000 Feb; 105(2 Pt 1):353-7. PubMed ID: 10669858
[TBL] [Abstract][Full Text] [Related]
6. Orange-induced skin lesions in patients with atopic eczema: evidence for a non-IgE-mediated mechanism.
Brockow K; Hautmann C; Fötisch K; Rakoski J; Borelli S; Vieths S; Ring J
Acta Derm Venereol; 2003; 83(1):44-8. PubMed ID: 12636022
[TBL] [Abstract][Full Text] [Related]
7. Serum eosinophil cationic protein (ECP) is a sensitive measure for disease activity in atopic dermatitis.
Czech W; Krutmann J; Schöpf E; Kapp A
Br J Dermatol; 1992 Apr; 126(4):351-5. PubMed ID: 1571256
[TBL] [Abstract][Full Text] [Related]
8. [The effect of suplatast tosilate on immunological parameters for the patients with atopic dermatitis].
Suto H; Mitsuishi K; Hira K; Uchida T; Unno T; Ogawa H; Yoshiike T; Takamori K
Arerugi; 2000 Dec; 49(12):1163-72. PubMed ID: 11197882
[TBL] [Abstract][Full Text] [Related]
9. [Characterization of nonresponders in high dosage UVA1 therapy of acute exacerbated atopic dermatitis].
Schempp CM; Effinger T; Czech W; Krutmann J; Simon JC; Schöpf E
Hautarzt; 1997 Feb; 48(2):94-9. PubMed ID: 9173067
[TBL] [Abstract][Full Text] [Related]
10. Effect of probiotic Lactobacillus strains in children with atopic dermatitis.
Rosenfeldt V; Benfeldt E; Nielsen SD; Michaelsen KF; Jeppesen DL; Valerius NH; Paerregaard A
J Allergy Clin Immunol; 2003 Feb; 111(2):389-95. PubMed ID: 12589361
[TBL] [Abstract][Full Text] [Related]
11. [The effect of suplatast tosilate on the patients with atopic dermatitis--relationship between clinical symptoms and immunological parameters].
Higashi N; Niimi Y; Aoki M; Fujimoto K; Suzuki K; Numano K; Kawana S
Arerugi; 2003 Nov; 52(11):1065-73. PubMed ID: 14685038
[TBL] [Abstract][Full Text] [Related]
12. High-dose UVA1 therapy in the treatment of patients with atopic dermatitis.
Krutmann J; Czech W; Diepgen T; Niedner R; Kapp A; Schöpf E
J Am Acad Dermatol; 1992 Feb; 26(2 Pt 1):225-30. PubMed ID: 1552057
[TBL] [Abstract][Full Text] [Related]
13. Correlations of serum Interleukin-16, total IgE, eosinophil cationic protein and total eosinophil counts with disease activity in children with atopic dermatitis.
Wu KG; Li TH; Chen CJ; Cheng HI; Wang TY
Int J Immunopathol Pharmacol; 2011; 24(1):15-23. PubMed ID: 21496383
[TBL] [Abstract][Full Text] [Related]
14. Effect and correlation of serum total IgE, eosinophil granule cationic proteins and sensitized allergens in atopic dermatitis patients with or without rhinitis.
Wu CS; Yu CL; Chang CH; Kuo WR; Lin HJ; Yu HS
Kaohsiung J Med Sci; 2002 May; 18(5):229-35. PubMed ID: 12197429
[TBL] [Abstract][Full Text] [Related]
15. Serum soluble IL-2 receptor (sIL-2R) and eosinophil cationic protein (ECP) levels in atopic dermatitis.
Furue M; Sugiyama H; Tsukamoto K; Ohtake N; Tamaki K
J Dermatol Sci; 1994 Apr; 7(2):89-95. PubMed ID: 8060919
[TBL] [Abstract][Full Text] [Related]
16. Activation markers in severe atopic dermatitis following extracorporeal photochemotherapy.
Radenhausen M; von Kobyletzki G; Höxtermann S; Altmeyer P; Hoffmann K
Acta Derm Venereol; 2003; 83(1):49-50. PubMed ID: 12636023
[No Abstract] [Full Text] [Related]
17. Interferon therapy for atopic dermatitis reduces basophil histamine release, but does not reduce serum IgE or eosinophilic proteins.
Nielsen BW; Reimert CM; Hammer R; Schiøtz PO; Thestrup-Pedersen K
Allergy; 1994 Feb; 49(2):120-8. PubMed ID: 7513506
[TBL] [Abstract][Full Text] [Related]
18. Soluble CD30 and cyclosporine in severe atopic dermatitis.
Caproni M; Salvatore E; Cardinali C; Brazzini B; Fabbri P
Int Arch Allergy Immunol; 2000 Apr; 121(4):324-8. PubMed ID: 10828723
[TBL] [Abstract][Full Text] [Related]
19. Medium-dose ultraviolet (UV) A1 vs. narrowband UVB phototherapy in atopic eczema: a randomized crossover study.
Gambichler T; Othlinghaus N; Tomi NS; Holland-Letz T; Boms S; Skrygan M; Altmeyer P; Kreuter A
Br J Dermatol; 2009 Mar; 160(3):652-8. PubMed ID: 19120333
[TBL] [Abstract][Full Text] [Related]
20. Correlation of eosinophils, eosinophil cationic protein and soluble interleukin-2 receptor with the clinical activity of atopic dermatitis.
Kägi MK; Joller-Jemelka H; Wüthrich B
Dermatology; 1992; 185(2):88-92. PubMed ID: 1421636
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
